HERE ARE some givens when dealing with the ethics of scientific research: 1. Federal funding and regulations can be controversial. Remove the funding and needless oversight and the only thing you will lose are groups that almost always propose government controls of biomedical regulations that reflect their own views and a belief in their own moral superiority. 2. The less government gets involved in creating forums for zealots and allowing them a hand in shaping guidelines for research funding, the better off scientific research will be.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.